EICHOR
● Active Not Recruiting
A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Ulcerative Colitis
Condition: Colitis, Ulcerative · Sponsor: Janssen Research & Development, LLC
About this study
The purpose of this study is to evaluate the efficacy of guselkumab in pediatric participants with moderately to severely active ulcerative colitis at the end of maintenance therapy among participants who were induction responders.
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (61)
| Children's Hospital Oakland | Oakland, California, United States | — |
| Riley Hospital for Children | Indianapolis, Indiana, United States | — |
| NYU Langone Health | Lake Success, New York, United States | — |
| The Kids Research Institute Australia on behalf of the Centre for Child Health Research | Nedlands, Australia | — |
| Mater Hospital Brisbane Inflammatory Bowel Diseases | South Brisbane, Australia | — |
| The Children's Hospital at Westmead | Westmead, Australia | — |
| CHU Charleroi Chimay | Charleroi, Belgium | — |
| UZ Gent | Ghent, Belgium | — |
| UZ Brussel | Jette, Belgium | — |
| UZ Leuven | Leuven, Belgium | — |
| Capital Center For Children's health Capital Medical University | Beijing, China | — |
| Peking University Third Hospital | Beijing, China | — |
+ 49 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06260163